Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response

Table 8

The relationship between mGPS and TNM stage (NSCLC only) and 12-month survival rate (%, SE).

Stage	mGPS			Total number of patients
	0	1	2
I	69% (19)	28% (12)	NC	62
II	37% (14)	17% (9)	NC	47
IIIa	20% (13)	42% (10)	0%	53
IIIb	20% (6)	6% (3)	14% (5)	154
IV	5% (3)	4% (2)	2% (2)	261
Total number of patients	153	225	173	—

NC: not calculated where 𝑁<10.